-
Sector Analysis
Asia Pacific (APAC) Renewable Energy Policy Handbook, 2024 Update
Asia Pacific (APAC) Renewable Energy Policy Report Overview All Asia Pacific (APAC) countries covered in this report have set targets for renewable energy deployment and generation. A few countries have capacity targets, and a few have generation targets. In the APAC region, feed-in tariff (FiT) has been predominantly the most popular form of incentive utilized to promote renewable power installations. However, competitive bidding or auctions have also gained popularity in the APAC countries to promote renewable energy, especially solar PV,...
-
Sector Analysis
Australia Renewable Energy Policy Handbook, 2024 Update
"Australia Renewable Energy Policy Handbook 2024” is among the latest country specific policy reports from GlobalData, the industry analysis specialist. The report offers comprehensive information on major policies governing the renewable energy market in the country and provides information on renewable policies/developments at a regional/municipal level. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides major technology specific...
-
Product Insights
Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview The artificial pancreas aids people in controlling their blood glucose level or diabetes, primarily type 1, automatically by continuously providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise artificial pancreas clinical trials outlook. The regulatory paths followed for conducting the artificial pancreas pipeline...
-
Product Insights
Unitywater – Aura and Harmony Trunk Infrastructure Program: Aura Water Project – Queensland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Unitywater – Aura and Harmony Trunk Infrastructure Program: Aura Water Project – Queensland report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Product Insights
Thromboembolic Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Thromboembolic Disease - Drugs In Development, 2023’, provides an overview of the Thromboembolic Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thromboembolic Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Hypoxic-Ischemic Encephalopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Hypoxic-Ischemic Encephalopathy - Drugs In Development, 2023’, provides an overview of the Hypoxic-Ischemic Encephalopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypoxic-Ischemic Encephalopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
West Nile Virus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘West Nile Virus Infections - Drugs In Development, 2023’, provides an overview of the West Nile Virus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for West Nile Virus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Helminthiasis (Parasitic Worm Infestation) – Drugs In Development, 2023
Global Markets Direct’s, ‘Helminthiasis (Parasitic Worm Infestation) - Drugs In Development, 2023’, provides an overview of the Helminthiasis (Parasitic Worm Infestation) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Helminthiasis (Parasitic Worm Infestation), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Drugs In Development, 2023’, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Yellow Fever – Drugs In Development, 2023
Global Markets Direct’s, ‘Yellow Fever - Drugs In Development, 2023’, provides an overview of the Yellow Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Yellow Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...